Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial, cells

Transplantation

Volumn 69, Issue 7, 2000, Pages 1408-1413

  Borger, P ^a   Kauffman, H F ^a   Timmerman, J A B ^a   Scholma, J ^a   Van Den Berg, J W K ^a   Koeter G H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

EID: 0034655756     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00034     Document Type: Article

References (28)

1. van den Berg JW, Postma DS, Koëter GH, van der Bij W. New immunosuppressive drugs and lung transplantation: last or least? Thorax 1999; 54: 550.
2. Muraoka K-I, Fujimoto K, Sun X, et al. Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-κB. J Clin Invest 1996; 97: 2433.
3. Zhang J-G, Walmsley MW, Moy JV, et al. Differential effects of cyclosporin A and tacrolimus on the production of TGF-β: implications for the development of obliterative bronchiolitis after lung transplantation. Transpl Int 1998; 11 (suppl 1): S325.
4. Khanna A, Cairns V, Hosenpud JD. Tacrolimus induces increased expression of transforming growth factor-β1 in mammalian lymphoid as well nonlymphoid cells. Transplantation 1999; 67: 614.
5. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporin induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530.
6. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807.
7. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature (Lond) 1992; 357: 695.
8. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA. FK-506- and CsA sensitive activation of the interleukin-2 promoter by calcineurin. Nature (Lond) 1992; 357: 692.
9. Frantz B, Nordby EC, Bren G, et al. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J 1994; 13: 861.
10. Matilla PS, Ullman KS, Fiering S, et al. The action of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 1990; 9: 4425.
11. Roger T, Out TA, Mukaida N, Matsushima K, Jansen HM, Lutter R. Enhanced AP-1 and NF-κB activities and stability of interleukin-8 (IL-8) are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem J 1998; 330: 429.
12. Borger P, Koëter GH, Timmerman JAB, Vellenga E, Tomee JFC, Kauffman HF. Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis 1999; 180: 1267.
13. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanism. Trends Pharmacol Sci 1995; 14: 436.
14. Scheinmann RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IκBα in mediation of immunesuppression by glucocorticoids. Science (Wash DC) 1995; 270: 283.
15. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through the induction of IκB synthesis. Science 1995; 270: 286.
16. LeVan TD, Behr FD, Adkins KK, Miesfeld RL, Bloom JW. Glucocorticoid receptor signaling in a bronchial epithelial cell line. Am J Physiol 1997; 272: L838.
17. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998; 12: 221.
18. Ransom JT. Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995; 17: 681.
19. Wu JC. Mycophenolate mofetil: molecular mechanisms of action. Perspect Drug Discovery 1994; 2: 185.
20. Laurent AF, Dumont S, Poindron P, Muller CD. Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Exp Hematol 1996; 24: 59.
21. DiGiovine B, Lynch JP III, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitisafter lung transplantation. J Immunol 1996; 157: 4194.
22. Charpin JM, Valcke J, Kettaneh L, Epardeau B, Stern M, Israël-Biet D. Peaks of transforming growth factor-β mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation 1998; 65: 752.
23. Scholma J, van der Bij W, Meekers JH, et al. Bronchoalveolar lavage in acute rejection and cytomegalovirus infection after lung transplantation. Abstract number J183, American Thoracic Society, San Francisco, 1997.
24. Shahar I, Fireman E, Topilsky M, et al. Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin Immunol Immunopathol 1996; 79: 244.
25. Horii Y, Muraguchi A, Iwano M, et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989; 143: 3949.
26. Bullingham RES, Nicholls A, Hale M. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transplant Proc 1996; 28: 925.
27. Bullingham R, Monroe S, Nicholls A, Hale M. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol 1996; 36: 315.
28. Mukaida N, Okamoto S-I, Ishikawa Y, Matsushima K. Molecular mechanisms of interleukin-8 gene expression. J Leukoc Biol 1994; 56: 554.